In mice with high-fat diet/streptozotocin-induced diabetes, Netrin-1 treatment increases insulin release from β-cells, promotes islet vascularization, reduces islet macrophage infiltration, and alleviates inflammation (Gao et al., 2016). The gene discussed is NTN1; the disease is diabetes mellitus.